TONIX PHARMACEUTICALS HOLDING CORP. Public Float
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) had Public Float of $271.37 million as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $271.37M.
- 2024-06-30: Entity Public Float $6.86M.
- 2023-06-30: Entity Public Float $17.00M.
- 2022-06-30: Entity Public Float $50.02M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $271.37M 10-K · filed 2026-03-12 |
| 2024-06-30 | $6.86M 10-K · filed 2025-03-18 |
| 2023-06-30 | $17.00M 10-K · filed 2024-04-01 |
| 2022-06-30 | $50.02M 10-K · filed 2023-03-13 |
| 2021-06-30 | $384.12M 10-K · filed 2022-03-14 |
| 2020-06-30 | $63.91B 10-K · filed 2021-03-15 |
| 2019-06-30 | $7.27B 10-K · filed 2020-03-24 |
| 2018-06-30 | $32.59M 10-K · filed 2019-03-18 |
| 2017-06-30 | $29.40M 10-K · filed 2018-03-09 |
| 2016-06-30 | $42.68B 10-K · filed 2017-04-13 |
| 2015-06-30 | $107.69M 10-K · filed 2016-03-03 |
| 2014-06-30 | $123.10M 10-K · filed 2015-02-27 |
| 2013-06-28 | $9.15M 10-K · filed 2014-03-28 |
| 2011-09-30 | $0.00 10-Q · filed 2011-10-07 |
| 2011-06-30 | $0.00 10-K/A · filed 2013-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |